Serum TRACP5b, a Marker of Bone Resorption, Is Associated With Adverse Cardiac Prognosis in Hospitalized Patients With Heart Failure

Serum TRACP5b, a Marker of Bone Resorption, Is Associated With Adverse Cardiac Prognosis in Hospitalized Patients With Heart Failure

Background: Tartrate-resistant acid phosphatase type 5b (TRACP5b) is derived from osteoclasts, and has been used as a marker of osteoporosis (bone resorption). Although heart failure (HF) is associated with catabolic bone remodelling, serum TRACP5b levels have not been rigourously examined in patien...

Full description

Bibliographic Details
Main Authors: Satoshi Abe, MD, PhD, Akiomi Yoshihisa, MD, PhD, Yasuhiro Ichijo, MD, PhD, Yusuke Kimishima, MD, PhD, Tetsuro Yokokawa, MD, PhD, Tomofumi Misaka, MD, PhD, Takamasa Sato, MD, PhD, Masayoshi Oikawa, MD, PhD, Atsushi Kobayashi, MD, PhD, Takashi Kaneshiro, MD, PhD, Kazuhiko Nakazato, MD, PhD, Yasuchika Takeishi, MD, PhD
Format: Article
Language:English
Published: Elsevier 2021-04-01
Series:CJC Open
Online Access:http://www.sciencedirect.com/science/article/pii/S2589790X20302146

Internet

http://www.sciencedirect.com/science/article/pii/S2589790X20302146

Similar Items